Growth Metrics

Erasca (ERAS) Other Non-Current Assets (2020 - 2026)

Erasca posted quarterly Other Non-Current Assets of $1.4 million for Q1 2026, down 44.7% year-on-year from $2.6 million in Q1 2025, and up 254.41% on a QoQ basis from $408000.0 in Q4 2025.

Erasca (ERAS) has 7 years of Other Non-Current Assets data on file, last reported at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 44.7% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 44.7% YoY), and the FY2025 full-year result was $408000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.4 million, up from $408000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.4 million in Q3 2023 and bottomed at $408000.0 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $408000.0 (2022), against an average of $1.3 million.
  • The widest annual swing landed in 2023, when Other Non-Current Assets surged 975.49%; it then slumped 90.69% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $408000.0 in 2022, then jumped by 974.26% to $4.4 million in 2023, then plunged by 90.69% to $408000.0 in 2024, then changed by 0.0% to $408000.0 in 2025, then surged by 254.41% to $1.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.4 million (Q1 2026), $408000.0 (Q4 2025), and $408000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Erasca 4.21 Bn 3.97 Bn - 1.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.45 Mn
Dec 31, 2025 408,000.00
Sep 30, 2025 408,000.00
Jun 30, 2025 408,000.00
Mar 31, 2025 2.62 Mn
Dec 31, 2024 408,000.00
Sep 30, 2024 3.88 Mn
Jun 30, 2024 408,000.00
Mar 31, 2024 408,000.00
Dec 31, 2023 4.38 Mn
Sep 30, 2023 4.39 Mn
Jun 30, 2023 408,000.00
Mar 31, 2023 408,000.00
Dec 31, 2022 408,000.00
Sep 30, 2022 408,000.00
Jun 30, 2022 408,000.00
Mar 31, 2022 408,000.00
Dec 31, 2021 2.91 Mn
Sep 30, 2021 408,000.00
Jun 30, 2021 408,000.00
Mar 31, 2021 408,000.00
Dec 31, 2020 312,000.00
Sep 30, 2020 408,000.00